Transplantation · 2004 · 28 citations · 24 references
Life SciencesImmunologyCell TherapyImmunoregulationTransplant ImmunologyAllograft RejectionGraft SurvivalGraft-versus-host DiseaseLiver Transplant ImmunosuppressionLiver TransplantationTransplant RejectionAllograft PreservationAlloreactive T Cell ResponsesDonor T-cell AlloreactivityEx Vivo ModelsGraft Versus Host Disease ModulationGraft-versus-host Disease PathophysiologyHepatic Graft-versus-host DiseaseT Cell-mediated Graft Rejection
BACKGROUND: Prolonged persistence of donor-derived T cells after organ transplantation has been proposed to improve long-term allograft survival. However, surviving transplant-derived T cells are also able to mediate devastating graft-versus-host disease (GvHD). Currently, GvHD after organ transplantation is usually refractory to conventional therapy and the disease outcome fatal. METHODS: Graft-reactive host T cells were generated ex vivo from a patient suffering from a severe and refractory liver-transplant-associated GvHD. To control GvHD, activated alloreactive host T cells were repetitively retransferred into the patient (activated host lymphocyte infusion [aHLI]). RESULTS: Adoptive transfer of ex vivo activated alloreactive host T cells (aHLI) led to the control and complete resolution of severe GvHD without inducing allograft rejection. CONCLUSIONS: aHLI opens a novel therapeutic window to control solid-organ transplant-associated GvHD while preserving allograft integrity.
24
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
Mark E. Dudley, John R. Wunderlich, Paul F. Robbins et al. · Science · 2002 · 2.8K citations · Full text
Life Sciences, Immunology, Oncology +17
Henrik Zetterquist · Tissue Antigens · 1992 · 1.8K citations
Life Sciences, Genetics, Immunology +17
H-J Kolb, J. Mittermüller, Ch. Clemm et al. · Blood · 1990 · 1.5K citations · Full text
Medicine, Hematology, Oncology +16